GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » CardioGenics Holdings Inc (OTCPK:CGNH) » Definitions » Equity-to-Asset

CardioGenics Holdings (CardioGenics Holdings) Equity-to-Asset : -3.20 (As of Jan. 2016)


View and export this data going back to 2004. Start your Free Trial

What is CardioGenics Holdings Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. CardioGenics Holdings's Total Stockholders Equity for the quarter that ended in Jan. 2016 was $-1.79 Mil. CardioGenics Holdings's Total Assets for the quarter that ended in Jan. 2016 was $0.56 Mil.

The historical rank and industry rank for CardioGenics Holdings's Equity-to-Asset or its related term are showing as below:

CGNH's Equity-to-Asset is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 0.58
* Ranked among companies with meaningful Equity-to-Asset only.

CardioGenics Holdings Equity-to-Asset Historical Data

The historical data trend for CardioGenics Holdings's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CardioGenics Holdings Equity-to-Asset Chart

CardioGenics Holdings Annual Data
Trend Jul06 Jul07 Jul08 Oct09 Oct10 Oct11 Oct12 Oct13 Oct14 Oct15
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.75 -0.44 -1.02 -4.28 -6.74

CardioGenics Holdings Quarterly Data
Apr11 Jul11 Oct11 Jan12 Apr12 Jul12 Oct12 Jan13 Apr13 Jul13 Oct13 Jan14 Apr14 Jul14 Oct14 Jan15 Apr15 Jul15 Oct15 Jan16
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.70 -5.76 -6.95 -6.74 -3.20

Competitive Comparison of CardioGenics Holdings's Equity-to-Asset

For the Diagnostics & Research subindustry, CardioGenics Holdings's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CardioGenics Holdings's Equity-to-Asset Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, CardioGenics Holdings's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where CardioGenics Holdings's Equity-to-Asset falls into.



CardioGenics Holdings Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

CardioGenics Holdings's Equity to Asset Ratio for the fiscal year that ended in Oct. 2015 is calculated as

Equity to Asset (A: Oct. 2015 )=Total Stockholders Equity/Total Assets
=-1.563/0.232
=

CardioGenics Holdings's Equity to Asset Ratio for the quarter that ended in Jan. 2016 is calculated as

Equity to Asset (Q: Jan. 2016 )=Total Stockholders Equity/Total Assets
=-1.787/0.558
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CardioGenics Holdings  (OTCPK:CGNH) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


CardioGenics Holdings Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of CardioGenics Holdings's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


CardioGenics Holdings (CardioGenics Holdings) Business Description

Traded in Other Exchanges
N/A
Address
6295 Northam Drive, Unit 8, Mississauga, ON, CAN, L4V 1W8
CardioGenics Holdings Inc is a biotechnology company. It is engaged in the development and commercialization of diagnostic test products for the In-Vitro Diagnostics (IVD) testing market. The company's objective is to create, develop and commercialize superior, innovative, cost-effective and patent-protected products for the IVD based on proprietary technologies. Its products include QL Care Analyzer, Immunoassay Tests, and Paramagnetic Beads. The business activity is primarily carried out through the region of Canada.

CardioGenics Holdings (CardioGenics Holdings) Headlines

No Headlines